Erasca, Inc. is a clinical stage precision oncology company. It focuses on discovering, developing, and commercializing therapies for patients with RAS/MAPK pathway-driven cancers. It has assembled a wholly owned or controlled RAS/MAPK pathway focused pipeline comprising modality-agnostic programs. The company was founded by Jonathan E. Lim and Kevan Shokat on July 2, 2018 and is headquartered in San Diego, CA.
Sector:
Health Technology
Industry:
Pharmaceuticals Major
Employees:
103
Frequently Asked Questions
Market cap, also known as market capitalization, is the total market value of a company. It's calculated by multiplying the current market price by the total number of shares outstanding. Erasca Inc market cap is $4.78B.
52 week high is the highest price of a stock in the past 52 weeks, or one year. Erasca Inc 52 week high is $24.28 as of November 22, 2026.
52 week low is the lowest price of a stock in the past 52 weeks, or one year. Erasca Inc 52 week low is $2.81 as of November 22, 2026.
Erasca Inc stock price today is $13.61.
Erasca Inc stock price yesterday was $14.22.
The Price-to-Earnings (or P/E) ratio is a commonly used tool for valuing a company. It's calculated by dividing the current share price by the earnings per share (or EPS). It can also be calculated by dividing the company's Market Cap by the Net Profit. Erasca Inc's P/E ratio is -13.66.
The Price-to-Book (P/B) ratio is a commonly used tool for valuing a company. It's calculated by dividing a company's market capitalization by its book value. Erasca Inc P/B ratio is 5.1997.
The 50-day moving average is a frequently used data point by active investors and traders to understand the trend of a stock. It's calculated by averaging the closing stock price over the previous 50 trading days. Erasca Inc 50-day moving average is $14.77.